|
1
|
Raggi A and Leonardi M: Burden of brain
disorders in Europe in 2017 and comparison with other
non-communicable disease groups. J Neurol Neurosurg Psychiatry.
91:104–105. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bautista-Aguilera OM, Ismaili L, Iriepa I,
Diez-Iriepa D, Chabchoub F, Marco-Contelles J and Pérez M: Tacrines
as therapeutic agents for alzheimer's disease. V. recent
developments. Chem Rec. 21:162–174. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bootcov MR, Bauskin AR, Valenzuela SM,
Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor
K, et al: MIC-1, a novel macrophage inhibitory cytokine, is a
divergent member of the TGF-beta superfamily. Proc Natl Acad Sci
USA. 94:11514–11519. 1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yokoyama-Kobayashi M, Saeki M, Sekine S
and Kato S: Human cDNA encoding a novel TGF-beta superfamily
protein highly expressed in placenta. J Biochem. 122:622–626.
1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bottner M, Laaff M, Schechinger B, Rappold
G, Unsicker K and Suter-Crazzolara C: Characterization of the rat,
mouse, and human genes of growth/differentiation
factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene.
237:105–111. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Koopmann J, Buckhaults P, Brown DA,
Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban
RH, et al: Serum macrophage inhibitory cytokine 1 as a marker of
pancreatic and other periampullary cancers. Clin Cancer Res.
10:2386–2392. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wiklund FE, Bennet AM, Magnusson PK,
Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin
P, Pedersen NL, et al: Macrophage inhibitory cytokine-1
(MIC-1/GDF15): A new marker of all-cause mortality. Aging Cell.
9:1057–1064. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Conte M, Martucci M, Chiariello A,
Franceschi C and Salvioli S: Mitochondria, immunosenescence and
inflammaging: A role for mitokines? Semin Immunopathol. 42:607–617.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rochette L, Zeller M, Cottin Y and Vergely
C: Insights into mechanisms of GDF15 and receptor GFRAL:
Therapeutic targets. Trends Endocrinol Metab. 31:939–951.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kang YE, Kim JM, Lim MA, Lee SE, Yi S, Kim
JT, Oh C, Liu L, Jin Y, Jung SN, et al: Growth differentiation
factor 15 is a cancer cell-induced mitokine that primes thyroid
cancer cells for invasiveness. Thyroid. 31:772–786. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nakayasu ES, Syed F, Tersey SA, Gritsenko
MA, Mitchell HD, Chan CY, Dirice E, Turatsinze JV, Cui Y, Kulkarni
RN, et al: Comprehensive proteomics analysis of stressed human
islets identifies GDF15 as a target for type 1 diabetes
intervention. Cell Metab. 31:363–374.e6. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang Y, Zhen C, Wang R and Wang G:
Growth-differentiation factor-15 predicts adverse cardiac events in
patients with acute coronary syndrome: A meta-analysis. Am J Emerg
Med. 37:1346–1352. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang L, Chang CC, Sun Z, Madsen D, Zhu H,
Padkjær SB, Wu X, Huang T, Hultman K, Paulsen SJ, et al: GFRAL is
the receptor for GDF15 and is required for the anti-obesity effects
of the ligand. Nat Med. 23:1158–1166. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mullican SE, Lin-Schmidt X, Chin CN,
Chavez JA, Furman JL, Armstrong AA, Beck SC, South VJ, Dinh TQ,
Cash-Mason TD, et al: GFRAL is the receptor for GDF15 and the
ligand promotes weight loss in mice and nonhuman primates. Nat Med.
23:1150–1157. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hsu JY, Crawley S, Chen M, Ayupova DA,
Lindhout DA, Higbee J, Kutach A, Joo W, Gao Z, Fu D, et al:
Non-homeostatic body weight regulation through a
brainstem-restricted receptor for GDF15. Nature. 550:255–259.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Emmerson PJ, Wang F, Du Y, Liu Q, Pickard
RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, et
al: The metabolic effects of GDF15 are mediated by the orphan
receptor GFRAL. Nat Med. 23:1215–1219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Borner T, Shaulson ED, Ghidewon MY,
Barnett AB, Horn CC, Doyle RP, Grill HJ, Hayes MR and De Jonghe BC:
GDF15 induces anorexia through Nausea and Emesis. Cell Metab.
31:351–362.e5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Klaus S, Igual Gil C and Ost M: Regulation
of diurnal energy balance by mitokines. Cell Mol Life Sci.
78:3369–3384. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kim DH, Lee D, Lim H, Choi SJ, Oh W, Yang
YS, Chang JH and Jeon HB: Effect of growth differentiation
factor-15 secreted by human umbilical cord blood-derived
mesenchymal stem cells on amyloid beta levels in in vitro and in
vivo models of Alzheimer's disease. Biochem Biophys Res Commun.
504:933–940. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kostuk EW, Cai J and Iacovitti L:
Subregional differences in astrocytes underlie selective
neurodegeneration or protection in Parkinson's disease models in
culture. Glia. 67:1542–1557. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Breniere C, Meloux A, Pedard M, Marie C,
Thouant P, Vergely C and Béjot Y: Growth differentiation factor-15
(GDF-15) is associated with mortality in ischemic stroke patients
treated with acute revascularization therapy. Front Neurol.
10(611)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li S, Wang Y, Cao B, Wu Y, Ji L, Li YX,
Liu M, Zhao Y, Qiao J, Wang H, et al: Maturation of growth
differentiation factor 15 in human placental trophoblast cells
depends on the interaction with Matrix Metalloproteinase-26. J Clin
Endocrinol Metab. 99:E2277–E2287. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Couture F, Sabbagh R, Kwiatkowska A,
Desjardins R, Guay SP, Bouchard L and Day R: PACE4 undergoes an
oncogenic alternative splicing switch in cancer. Cancer Res.
77:6863–6879. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fairlie WD, Russell PK, Wu WM, Moore AG,
Zhang HP, Brown PK, Bauskin AR and Breit SN: Epitope mapping of the
transforming growth factor-beta superfamily protein, macrophage
inhibitory cytokine-1 (MIC-1): Identification of at least five
distinct epitope specificities. Biochemistry. 40:65–73.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bauskin AR, Zhang HP, Fairlie WD, He XY,
Russell PK, Moore AG, Brown DA, Stanley KK and Breit SN: The
propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta
superfamily member, acts as a quality control determinant for
correctly folded MIC-1. EMBO J. 19:2212–2220. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bauskin AR, Jiang L, Luo XW, Wu L, Brown
DA and Breit SN: The TGF-beta superfamily cytokine MIC-1/GDF15:
secretory mechanisms facilitate creation of latent stromal stores.
J Interferon Cytokine Res. 30:389–397. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bauskin AR, Brown DA, Junankar S, Rasiah
KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ,
et al: The propeptide mediates formation of stromal stores of
PROMIC-1: Role in determining prostate cancer outcome. Cancer Res.
65:2330–2336. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tsai VWW, Husaini Y, Sainsbury A, Brown DA
and Breit SN: The MIC-1/GDF15-GFRAL pathway in energy homeostasis:
Implications for obesity, cachexia, and other associated diseases.
Cell Metab. 28:353–368. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wollert KC, Kempf T and Wallentin L:
Growth differentiation factor 15 as a biomarker in cardiovascular
disease. Clin Chem. 63:140–151. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Demir O, Barros EP, Offutt TL, Rosenfeld M
and Amaro RE: An integrated view of p53 dynamics, function, and
reactivation. Curr Opin Struct Biol. 67:187–194. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tan M, Wang Y, Guan K and Sun Y:
PTGF-beta, a type beta transforming growth factor (TGF-beta)
superfamily member, is a p53 target gene that inhibits tumor cell
growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA.
97:109–114. 2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kannan K, Amariglio N, Rechavi G and Givol
D: Profile of gene expression regulated by induced p53: Connection
to the TGF-beta family. FEBS Lett. 470:77–82. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li PX, Wong J, Ayed A, Ngo D, Brade AM,
Arrowsmith C, Austin RC and Klamut HJ: Placental transforming
growth factor-beta is a downstream mediator of the growth arrest
and apoptotic response of tumor cells to DNA damage and p53
overexpression. J Biol Chem. 275:20127–20135. 2000.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yang H, Filipovic Z, Brown D, Breit SN and
Vassilev LT: Macrophage inhibitory cytokine-1: A novel biomarker
for p53 pathway activation. Mol Cancer Ther. 2:1023–1029.
2003.PubMed/NCBI
|
|
35
|
Tiwari KK, Moorthy B and Lingappan K: Role
of GDF15 (growth and differentiation factor 15) in pulmonary oxygen
toxicity. Toxicol In Vitro. 29:1369–1376. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kim Y, Noren Hooten N and Evans MK: CRP
stimulates GDF15 expression in endothelial cells through p53.
Mediators Inflamm. 2018(8278039)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742.
2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Osada M, Park HL, Park MJ, Liu JW, Wu G,
Trink B and Sidransky D: A p53-type response element in the GDF15
promoter confers high specificity for p53 activation. Biochem
Biophys Res Commun. 354:913–918. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pagel JI and Deindl E: Disease progression
mediated by egr-1 associated signaling in response to oxidative
stress. Int J Mol Sci. 13:13104–13117. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Baek SJ, Kim JS, Nixon JB, DiAugustine RP
and Eling TE: Expression of NAG-1, a transforming growth
factor-beta superfamily member, by troglitazone requires the early
growth response gene EGR-1. J Biol Chem. 279:6883–6892.
2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Baek SJ, Kim JS, Moore SM, Lee SH,
Martinez J and Eling TE: Cyclooxygenase inhibitors induce the
expression of the tumor suppressor gene EGR-1, which results in the
upregulation of NAG-1, an antitumorigenic protein. Mol Pharmacol.
67:356–364. 2005.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chintharlapalli S, Papineni S, Baek SJ,
Liu S and Safe S:
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome
proliferator-activated receptor gamma agonists but decrease HCT-116
colon cancer cell survival through receptor-independent activation
of early growth response-1 and nonsteroidal anti-inflammatory
drug-activated gene-1. Mol Pharmacol. 68:1782–1792. 2005.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kadowaki M, Yoshioka H, Kamitani H,
Watanabe T, Wade PA and Eling TE: DNA methylation-mediated
silencing of nonsteroidal anti-inflammatory drug-activated gene
(NAG-1/GDF15) in glioma cell lines. Int J Cancer. 130:267–277.
2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Woo SM, Min KJ, Kim S, Park JW, Kim DE,
Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, et al: Silibinin induces
apoptosis of HT29 colon carcinoma cells through early growth
response-1 (EGR-1)-mediated non-steroidal anti-inflammatory
drug-activated gene-1 (NAG-1) upregulation. Chem Biol Interact.
211:36–43. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kong J, Sun W, Zhu W, Liu C, Zhang H and
Wang H: Long noncoding RNA LINC01133 inhibits oral squamous cell
carcinoma metastasis through a feedback regulation loop with GDF15.
J Surg Oncol. 118:1326–1334. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Xiong X, Yuan J, Zhang N, Zheng Y, Liu J
and Yang M: Silencing of lncRNA PVT1 by miR-214 inhibits the
oncogenic GDF15 signaling and suppresses hepatocarcinogenesis.
Biochem Biophys Res Commun. 521:478–484. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Guo LL and Wang SF: Downregulated long
noncoding RNA GAS5 fails to function as decoy of CEBPB, resulting
in increased GDF15 expression and rapid ovarian cancer cell
proliferation. Cancer Biother Radiopharm. 34:537–546.
2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Liu B, Li J and Cairns MJ: Identifying
miRNAs, targets and functions. Brief Bioinform. 15:1–19.
2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Teng MS, Hsu LA, Juan SH, Lin WC, Lee MC,
Su CW, Wu S and Ko YL: A GDF15 3' UTR variant, rs1054564, results
in allele-specific translational repression of GDF15 by
hsa-miR-1233-3p. PLoS One. 12(e0183187)2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jones MF, Li XL, Subramanian M, Shabalina
SA, Hara T, Zhu Y, Huang J, Yang Y, Wakefield LM, Prasanth KV and
Lal A: Growth differentiation factor-15 encodes a novel microRNA
3189 that functions as a potent regulator of cell death. Cell Death
Differ. 22:1641–1653. 2015.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Coll AP, Chen M, Taskar P, Rimmington D,
Patel S, Tadross JA, Cimino I, Yang M, Welsh P, Virtue S, et al:
GDF15 mediates the effects of metformin on body weight and energy
balance. Nature. 578:444–448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Melvin A, Chantzichristos D, Kyle CJ,
Mackenzie SD, Walker BR, Johannsson G, Stimson RH and O'Rahilly S:
GDF15 is elevated in conditions of glucocorticoid deficiency and is
modulated by glucocorticoid replacement. J Clin Endocrinol Metab.
105:1427–1434. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Campderros L, Moure R, Cairo M,
Gavaldà-Navarro A, Quesada-López T, Cereijo R, Giralt M, Villarroya
J and Villarroya F: Brown Adipocytes Secrete GDF15 in response to
thermogenic activation. Obesity (Silver Spring). 27:1606–1616.
2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zhao J, Li M, Chen Y, Zhang S, Ying H,
Song Z, Lu Y, Li X, Xiong X and Jiang J: Elevated serum growth
differentiation Factor 15 levels in hyperthyroid patients. Front
Endocrinol (Lausanne). 9(793)2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Liu H, Dai W, Cui Y, Lyu Y and Li Y:
Potential associations of circulating growth differentiation
factor-15 with sex hormones in male patients with coronary artery
disease. Biomed Pharmacother. 114(108792)2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ha G, De Torres F, Arouche N, Benzoubir N,
Ferratge S, Hatem E, Anginot A and Uzan G: GDF15 secreted by
senescent endothelial cells improves vascular progenitor cell
functions. PLoS One. 14(e0216602)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Jin YJ, Lee JH, Kim YM, Oh GT and Lee H:
Macrophage inhibitory cytokine-1 stimulates proliferation of human
umbilical vein endothelial cells by up-regulating cyclins D1 and E
through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F
activation signaling pathways. Cell Signal. 24:1485–1495.
2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Song H, Yin D and Liu Z: GDF-15 promotes
angiogenesis through modulating p53/HIF-1α signaling pathway in
hypoxic human umbilical vein endothelial cells. Mol Biol Rep.
39:4017–4022. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wang S, Li M, Zhang W, Hua H, Wang N, Zhao
J, Ge J, Jiang X, Zhang Z, Ye D and Yang C: Growth differentiation
factor 15 promotes blood vessel growth by stimulating cell cycle
progression in repair of critical-sized calvarial defect. Sci Rep.
7(9027)2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Lugano R, Ramachandran M and Dimberg A:
Tumor angiogenesis: causes, consequences, challenges and
opportunities. Cell Mol Life Sci. 77:1745–1770. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Dong G, Zheng QD, Ma M, Wu SF, Zhang R,
Yao RR, Dong YY, Ma H, Gao DM, Ye SL, et al: Angiogenesis enhanced
by treatment damage to hepatocellular carcinoma through the release
of GDF15. Cancer Med. 7:820–830. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Whitson RJ, Lucia MS and Lambert JR:
Growth differentiation factor-15 (GDF-15) suppresses in vitro
angiogenesis through a novel interaction with connective tissue
growth factor (CCN2). J Cell Biochem. 114:1424–1433.
2013.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Kist M and Vucic D: Cell death pathways:
Intricate connections and disease implications. EMBO J.
40(e106700)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zhu S, Yang N, Guan Y, Wang X, Zang G, Lv
X, Deng S, Wang W, Li T and Chen J: GDF15 promotes glioma stem
cell-like phenotype via regulation of ERK1/2-c-Fos-LIF signaling.
Cell Death Discov. 7(3)2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Zhang W, Hu C, Wang X, Bai S, Cao S,
Kobelski M, Lambert JR, Gu J and Zhan Y: Role of GDF15 in
methylseleninic acid-mediated inhibition of cell proliferation and
induction of apoptosis in prostate cancer cells. PLoS One.
14(e0222812)2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Liu T, Bauskin AR, Zaunders J, Brown DA,
Pankhurst S, Russell PJ and Breit SN: Macrophage inhibitory
cytokine 1 reduces cell adhesion and induces apoptosis in prostate
cancer cells. Cancer Res. 63:5034–5040. 2003.PubMed/NCBI
|
|
68
|
Schlittenhardt D, Schober A, Strelau J,
Bonaterra GA, Schmiedt W, Unsicker K, Metz J and Kinscherf R:
Involvement of growth differentiation factor-15/macrophage
inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of
human macrophages in vitro and in arteriosclerotic lesions. Cell
Tissue Res. 318:325–333. 2004.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Tarfiei GA, Shadboorestan A, Montazeri H,
Rahmanian N, Tavosi G and Ghahremani MH: GDF15 induced apoptosis
and cytotoxicity in A549 cells depends on TGFBR2 expression. Cell
Biochem Funct. 37:320–330. 2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Li J, Yang L, Qin W, Zhang G, Yuan J and
Wang F: Adaptive induction of growth differentiation factor 15
attenuates endothelial cell apoptosis in response to high glucose
stimulus. PLoS One. 8(e65549)2013.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Nickel N, Jonigk D, Kempf T, Bockmeyer CL,
Maegel L, Rische J, Laenger F, Lehmann U, Sauer C, Greer M, et al:
GDF-15 is abundantly expressed in plexiform lesions in patients
with pulmonary arterial hypertension and affects proliferation and
apoptosis of pulmonary endothelial cells. Respir Res.
12(62)2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Suriben R, Chen M, Higbee J, Oeffinger J,
Ventura R, Li B, Mondal K, Gao Z, Ayupova D, Taskar P, et al:
Antibody-mediated inhibition of GDF15-GFRAL activity reverses
cancer cachexia in mice. Nat Med. 26:1264–1270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Chrysovergis K, Wang X, Kosak J, Lee SH,
Kim JS, Foley JF, Travlos G, Singh S, Baek SJ and Eling TE:
NAG-1/GDF-15 prevents obesity by increasing thermogenesis,
lipolysis and oxidative metabolism. Int J Obes (Lond).
38:1555–1564. 2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Tsai VW, Zhang HP, Manandhar R, Schofield
P, Christ D, Lee-Ng KKM, Lebhar H, Marquis CP, Husaini Y, Brown DA
and Breit SN: GDF15 mediates adiposity resistance through actions
on GFRAL neurons in the hindbrain AP/NTS. Int J Obes (Lond).
43:2370–2380. 2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhang Z, Xu X, Tian W, Jiang R, Lu Y, Sun
Q, Fu R, He Q, Wang J, Liu Y, et al: ARRB1 inhibits non-alcoholic
steatohepatitis progression by promoting GDF15 maturation. J
Hepatol. 72:976–989. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Zhang M, Sun W, Qian J and Tang Y: Fasting
exacerbates hepatic growth differentiation factor 15 to promote
fatty acid β-oxidation and ketogenesis via activating XBP1
signaling in liver. Redox Biol. 16:87–96. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Luan HH, Wang A, Hilliard BK, Carvalho F,
Rosen CE, Ahasic AM, Herzog EL, Kang I, Pisani MA, Yu S, et al:
GDF15 is an inflammation-induced central mediator of tissue
tolerance. Cell. 178:1231–1244.e11. 2019.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Wu Q, Jiang D, Schaefer NR, Harmacek L,
O'Connor BP, Eling TE, Eickelberg O and Chu HW: Overproduction of
growth differentiation factor 15 promotes human rhinovirus
infection and virus-induced inflammation in the lung. Am J Physiol
Lung Cell Mol Physiol. 314:L514–L527. 2018.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Abulizi P, Loganathan N, Zhao D, Mele T,
Zhang Y, Zwiep T, Liu K and Zheng X: Growth differentiation
factor-15 deficiency augments inflammatory response and exacerbates
septic heart and renal injury induced by lipopolysaccharide. Sci
Rep. 7(1037)2017.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Li A, Zhao F, Zhao Y, Liu H and Wang Z:
ATF4-mediated GDF15 suppresses LPS-induced inflammation and MUC5AC
in human nasal epithelial cells through the PI3K/Akt pathway. Life
Sci. 275(119356)2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Li M, Song K, Huang X, Fu S and Zeng Q:
GDF15 prevents LPS and D-galactosamine-induced inflammation and
acute liver injury in mice. Int J Mol Med. 42:1756–1764.
2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Hu X, Wang T and Jin F: Alzheimer's
disease and gut microbiota. Sci China Life Sci. 59:1006–1023.
2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Chen YG: Research progress in the
pathogenesis of Alzheimer's disease. Chin Med J (Engl).
131:1618–1624. 2018.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Strelau J, Sullivan A, Bottner M, Lingor
P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J,
Krieglstein K and Unsicker K: Growth/differentiation
factor-15/macrophage inhibitory cytokine-1 is a novel trophic
factor for midbrain dopaminergic neurons in vivo. J Neurosci.
20:8597–8603. 2000.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Schober A, Bottner M, Strelau J, Kinscherf
R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN and
Unsicker K: Expression of growth differentiation
factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the
perinatal, adult, and injured rat brain. J Comp Neurol. 439:32–45.
2001.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Fuchs T, Trollor JN, Crawford J, Brown DA,
Baune BT, Samaras K, Campbell L, Breit SN, Brodaty H, Sachdev P and
Smith E: Macrophage inhibitory cytokine-1 is associated with
cognitive impairment and predicts cognitive decline-the Sydney
memory and aging study. Aging Cell. 12:882–889. 2013.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Chai YL, Hilal S, Chong JPC, Ng YX, Liew
OW, Xu X, Ikram MK, Venketasubramanian N, Richards AM, Lai MKP and
Chen CP: Growth differentiation factor-15 and white matter
hyperintensities in cognitive impairment and dementia. Medicine
(Baltimore). 95(e4566)2016.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Low JK, Ambikairajah A, Shang K, Brown DA,
Tsai VW, Breit SN and Karl T: First behavioural characterisation of
a knockout mouse model for the transforming growth factor (TGF)-β
superfamily cytokine, MIC-1/GDF15. PLoS One.
12(e0168416)2017.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Nasrabady SE, Rizvi B, Goldman JE and
Brickman AM: White matter changes in Alzheimer's disease: A focus
on myelin and oligodendrocytes. Acta Neuropathol Commun.
6(22)2018.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Jiang J, Trollor JN, Brown DA, Crawford
JD, Thalamuthu A, Smith E, Breit SN, Liu T, Brodaty H, Baune BT, et
al: An inverse relationship between serum macrophage inhibitory
cytokine-1 levels and brain white matter integrity in
community-dwelling older individuals. Psychoneuroendocrinology.
62:80–88. 2015.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Jiang J, Wen W, Brown DA, Crawford J,
Thalamuthu A, Smith E, Breit SN, Liu T, Zhu W, Brodaty H, et al:
The relationship of serum macrophage inhibitory cytokine-1 levels
with gray matter volumes in community-dwelling older individuals.
PLoS One. 10(e0123399)2015.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Mu Y and Gage FH: Adult hippocampal
neurogenesis and its role in Alzheimer's disease. Mol Neurodegener.
6(85)2011.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Strelau J, Strzelczyk A, Rusu P, Bendner
G, Wiese S, Diella F, Altick AL, von Bartheld CS, Klein R, Sendtner
M and Unsicker K: Progressive postnatal motoneuron loss in mice
lacking GDF-15. J Neurosci. 29:13640–13648. 2009.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Carrillo-Garcia C, Prochnow S, Simeonova
IK, Strelau J, Hölzl-Wenig G, Mandl C, Unsicker K, von Bohlen Und
Halbach O and Ciccolini F: Growth/differentiation factor 15
promotes EGFR signalling, and regulates proliferation and migration
in the hippocampus of neonatal and young adult mice. Development.
141:773–783. 2014.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Kim DH, Lee D, Chang EH, Kim JH, Hwang JW,
Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, et al: GDF-15 secreted
from human umbilical cord blood mesenchymal stem cells delivered
through the cerebrospinal fluid promotes hippocampal neurogenesis
and synaptic activity in an Alzheimer's disease model. Stem Cells
Dev. 24:2378–2390. 2015.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Sudhof TC: Molecular neuroscience in the
21st Century: A personal perspective. Neuron. 96:536–541.
2017.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Liu DD, Lu JM, Zhao QR, Hu C and Mei YA:
Growth differentiation factor-15 promotes glutamate release in
medial prefrontal cortex of mice through upregulation of T-type
calcium channels. Sci Rep. 6(28653)2016.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Ballard C, Gauthier S, Corbett A, Brayne
C, Aarsland D and Jones E: Alzheimer's disease. Lancet.
377:1019–1031. 2011.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Tesseur I, Zou K, Esposito L, Bard F,
Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, et al:
Deficiency in neuronal TGF-beta signaling promotes
neurodegeneration and Alzheimer's pathology. J Clin Invest.
116:3060–3069. 2006.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Das P and Golde T: Dysfunction of TGF-beta
signaling in Alzheimer's disease. J Clin Invest. 116:2855–2857.
2006.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Koh SH and Park HH: Neurogenesis in stroke
recovery. Transl Stroke Res. 8:3–13. 2017.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Barthels D and Das H: Current advances in
ischemic stroke research and therapies. Biochim Biophys Acta Mol
Basis Dis. 1866(165260)2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Xiang Y, Zhang T, Guo J, Peng YF and Wei
YS: The association of growth differentiation factor-15 gene
polymorphisms with growth differentiation factor-15 serum levels
and risk of ischemic stroke. J Stroke Cerebrovasc Dis.
26:2111–2119. 2017.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Brown DA, Breit SN, Buring J, Fairlie WD,
Bauskin AR, Liu T and Ridker PM: Concentration in plasma of
macrophage inhibitory cytokine-1 and risk of cardiovascular events
in women: A nested case-control study. Lancet. 359:2159–2163.
2002.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Worthmann H, Kempf T, Widera C, Tryc AB,
Goldbecker A, Ma YT, Deb M, Tountopoulou A, Lambrecht J, Heeren M,
et al: Growth differentiation factor 15 plasma levels and outcome
after ischemic stroke. Cerebrovasc Dis. 32:72–78. 2011.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Yin J, Zhu Z, Guo D, Wang A, Zeng N, Zheng
X, Peng Y, Zhong C, Wang G, Zhou Y, et al: Increased growth
differentiation factor 15 is associated with unfavorable clinical
outcomes of acute ischemic stroke. Clin Chem. 65:569–578.
2019.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Groschel K, Schnaudigel S, Edelmann F,
Niehaus CF, Weber-Krüger M, Haase B, Lahno R, Seegers J, Wasser K,
Wohlfahrt J, et al: Growth-differentiation factor-15 and functional
outcome after acute ischemic stroke. J Neurol. 259:1574–1579.
2012.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Dong X and Nao J: Association of serum
growth differentiation factor 15 level with acute ischemic stroke
in a Chinese population. Int J Neurosci. 129:1247–1255.
2019.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Wang X, Zhu L, Wu Y, Sun K, Su M, Yu L,
Chen J, Li W, Yang J, Yuan Z and Hui R: Plasma growth
differentiation factor 15 predicts first-ever stroke in
hypertensive patients. Medicine (Baltimore).
95(e4342)2016.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Schindowski K, von Bohlen und Halbach O,
Strelau J, Ridder DA, Herrmann O, Schober A, Schwaninger M and
Unsicker K: Regulation of GDF-15, a distant TGF-β superfamily
member, in a mouse model of cerebral ischemia. Cell Tissue Res.
343:399–409. 2011.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Dickson DW: Neuropathology of Parkinson
disease. Parkinsonism Relat Disord. 46 (Suppl 1):S30–S33.
2018.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Obeso JA, Rodriguez-Oroz MC, Goetz CG,
Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH
and Halliday G: Missing pieces in the Parkinson's disease puzzle.
Nat Med. 16:653–661. 2010.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Maetzler W, Deleersnijder W, Hanssens V,
Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW,
Roncoroni L, Schaeffer E, et al: GDF15/MIC1 and MMP9 cerebrospinal
fluid levels in Parkinson's disease and lewy body dementia. PLoS
One. 11(e0149349)2016.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Movement Disorder Society Task Force on
Rating Scales for Parkinson's Disease. The unified Parkinson's
disease rating scale (UPDRS): Status and recommendations. Mov
Disord. 18:738–750. 2003.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Yao X, Wang D, Zhang L, Wang L, Zhao Z,
Chen S, Wang X, Yue T and Liu Y: Serum growth differentiation
factor 15 in Parkinson disease. Neurodegener Dis. 17:251–260.
2017.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Luthman J, Fredriksson A, Sundstrom E,
Jonsson G and Archer T: Selective lesion of central dopamine or
noradrenaline neuron systems in the neonatal rat: Motor behavior
and monoamine alterations at adult stage. Behav Brain Res.
33:267–277. 1989.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Machado V, Haas SJ, von Bohlen Und Halbach
O, Wree A, Krieglstein K, Unsicker K and Spittau B:
Growth/differentiation factor-15 deficiency compromises
dopaminergic neuron survival and microglial response in the
6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol
Dis. 88:1–15. 2016.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Machado V, Gilsbach R, Das R, Schober A,
Bogatyreva L, Hauschke D, Krieglstein K, Unsicker K and Spittau B:
Gdf-15 deficiency does not alter vulnerability of nigrostriatal
dopaminergic system in MPTP-intoxicated mice. Cell Tissue Res.
365:209–223. 2016.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Hirsch E, Graybiel AM and Agid YA:
Melanized dopaminergic neurons are differentially susceptible to
degeneration in Parkinson's disease. Nature. 334:345–348.
1988.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Liu H, Liu J, Si L, Guo C, Liu W and Liu
Y: GDF-15 promotes mitochondrial function and proliferation in
neuronal HT22 cells. J Cell Biochem. 120:10530–10547.
2019.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Miyaue N, Yabe H and Nagai M: Serum growth
differentiation factor 15, but not lactate, is elevated in patients
with Parkinson's disease. J Neurol Sci. 409(116616)2020.PubMed/NCBI View Article : Google Scholar
|
